Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 12, 2002, Pages 1531-1543

  Kaaks, Rudolf ^a   Lukanova, Annekatrin ^b   Kurzer, Mindy S ^c  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c Department of Food Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DIMETHISTERONE; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; GLUCOSE; INSULIN; MESSENGER RNA; ORACON; ORAL CONTRACEPTIVE AGENT; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; TESTOSTERONE;

BODY WEIGHT; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DRUG FORMULATION; ENDOMETRIUM CANCER; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; GENETIC PREDISPOSITION; GYNECOLOGIC CANCER; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; OBESITY; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

AGE DISTRIBUTION; AGED; ANDROGENS; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN; MIDDLE AGED; OBESITY; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN;

EID: 0036907571     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (247)

1. Cancer incidence in five continents. In: D. M. Parkin, S. L. Whelan, J. Ferlay, L. Raymond, and J. Young (eds.), IARC Scientific, Publication, No. 143, Vol. VII, pp. 1-1240. Lyon, France: International Agency for Research on Cancer, 1997.
2. Pisani, P., Parkin, D. M., and Ferlay, J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int. J. Cancer, 55: 891-903, 1993.
3. Coleman, M. P., Esteve, J., Damiecki, P., Arslan, A., and Renard, H. Trends in Cancer Incidence and Mortality. IARC Sci. Publ., 1-806. Lyon, France: International Agency for Research on Cancer, 1993.
4. Cancer. In: G. Cannon (ed.), Food, Nutrition and the Prevention of Cancer: A Global Perspective, pp. 36-52. Washington, DC: World Cancer Research Fund, American Institute for Cancer Research, 1997.
5. Grady, D., and Ernster, V. L. Endometrial cancer. In: D. Schottenfeld and F. J. Fraumeni (eds.), Cancer Epidemiology and Prevention, pp. 1058-1089. New York: Oxford University Press, 1996.
6. Haenszel, W., and Kurihara, M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J. Natl. Cancer Inst. (Bethesda), 40: 43-68, 1968.
7. Dunn, J. E. Cancer epidemiology in populations of the United States - With emphasis on Hawaii and California - And Japan. Cancer Res., 35: 3240-3245, 1975.
8. Armstrong, B., and Doll, R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int. J. Cancer, 15: 617-631, 1975.
9. Hill, H. A., and Austin, H. Nutrition and endometrial cancer. Cancer Causes Control, 7: 19-32, 1996.
10. Weight control and physical activity. In: H. Vaino and F. Bianchini (eds), IARC Handbook for Cancer Prevention Vol. 6, pp. 1-315. Lyon, France: IARC Press, 2002.
11. Bergstrom, A., Pisani, P., Tenet, V., Wolk, A., and Adami, H. O. Overweight as an avoidable cause of cancer in Europe. Int. J. Cancer. 91: 421-430, 2001.
12. Tornberg, S. A., and Carstensen, J. M. Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years. Br. J. Cancer, 69: 358-361, 1994.
13. La Vecchia, C., Parazzini, F., Negri, E., Fasoli, M., Gentile, A., and Franceschi, S. Anthropometric indicators of endometrial cancer risk. Eur. J. Cancer, 27: 487-490, 1991.
14. Hormonal contraception and postmenopausal hormonal therapy. In: IARC Working Group on the Evaluation of Carcinogenic Risks in Humans (Ed.), IARC Monographs, Vol. 72, pp. 1-660. Lyon: International Agency for Research on Cancer, 1999.
15. Emons, G., Fleckenstein, G., Hinney, B., Huschmand, A., and Heyl, W. Hormonal interactions in endometrial cancer. Endocr. Relat. Cancer, 7: 227-242, 2000.
16. Rose, P. G. Endometrial carcinoma. N. Engl. J. Med., 335: 640-649, 1996.
17. Weiss, N. S., and Hill, D. A. Postmenopausal estrogens and progestogens and the incidence of gynecologic cancer. Maturitas. 23: 235-239, 1996.
18. Potischman, N., Hoover, R. N., Brinton, L. A., Siiteri, P., Dorgan, J. F., Swanson, C. A., Berman, M. L., Mortel, R., Twiggs, L. B., Barrett, R. J., Wilbanks, G. D., Persky, V., and Lurain, J. R. Case-control study of endogenous steroid hormones and endometrial cancer. J. Natl. Cancer Inst. (Bethesda). 88: 1127-1135, 1996.
19. Austin, H., Austin, J. M., Jr., Partridge, E. E., Hatch, K. D., and Shingleton, H. M. Endometrial cancer, obesity, and body fat distribution. Cancer Res., 51: 568-572, 1991.
20. Mollerstrom, G., Carlstrom, K., Lagrelius, A., and Einhorn, N. Is there an altered steroid profile in patients with endometrial carcinoma? Cancer (Phila.), 72: 173-181, 1993.
21. Troisi, R., Potischman, N., Hoover, R. N., Siiteri, P., and Brinton, L. A. Insulin and endometrial cancer. Am. J. Epidemiol., 146: 476-482, 1997.
22. Kaaks, R., and Lukanova, A. Energy balance and cancer: The role of insulin and insulin-like growth factor-1. Proc. Nutr. Soc., 60: 91-106, 2001.
23. Key, T. J., Allen, N. E., Verkaslo, P. K., and Banks, E. Energy balance and cancer: The role of sex hormones. Proc. Nutr. Soc., 60: 81-89, 2001.
24. Sherman, M. E. Theories of endometrial carcinogenesis: A multidisciplinary approach. Mod. Pathol., 13: 295-308, 2000.
25. Bokhman, J. V. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol., 15: 10-17, 1983.
26. Deligdisch, L., and Cohen, C. J. Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia. Cancer (Phila.), 56: 1452-1455, 1985.
27. Ames, B. N., Shigenaga, M. K., and Gold, L. S. DNA lesions, inducible DNA repair, and cell division: Three key factors in mutagenesis and carcinogenesis. Environ. Health Perspect., 101 (Suppl. 5): 35-44, 1993.
28. Cohen, S. M., and Ellwein, L. B. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res., 51: 6493-6505, 1991.
29. Ames, B. N., and Gold, L. S. Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science (Wash. DC). 249: 970-971, 1990.
30. Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A., and Henderson, B. E. Increased cell division as a cause of human cancer. Cancer Res., 50: 7415-7421, 1990.
31. Cory, S., Vaux, D. L., Strasser, A., Harris, A. W., and Adams, J. M. Insights from Bcl-2 and Myc: Malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res., 59: 1685s-1692s, 1999.
32. Russo, J., Tay, L. K., and Russo, I. H. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat., 2: 5-73, 1982.
33. Scott, R. E., and Maercklein, P. B. An initiator of carcinogenesis selectively and stably inhibits stem cell differentiation: A concept that initiation of carcinogenesis involves multiple phases. Proc. Natl. Acad. Sci. USA, 82: 2995-2999, 1985.
34. Wille, J. J., Jr., Maercklein, P. B., and Scott, R. E. Neoplastic transformation and defective control of cell proliferation and differentiation. Cancer Res., 42: 5139-5146, 1982.
35. Siiteri, P. K. Steroid hormones and endometrial cancer. Cancer Res., 38: 4360-4366, 1978.
36. Key, T. J., and Pike, M. C. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk. Br. J. Cancer, 57: 205-212, 1988.
37. Ferenczy, A., Bertrand, G., and Gelfand, M. M. Proliferation kinetics of human endometrium during the normal menstrual cycle. Am. J. Obstet. Gynecol., 133: 859-867, 1979.
38. Giudice, L. C., Lamson, G., Rosenfeld, R. G., and Irwin, J. C. Insulin-like growth factor-II (IGF-II) and IGF binding proteins in human endometrium. Ann. N. Y. Acad. Sci., 626: 295-307, 1991.
39. Murphy, L. J., and Ghahary, A. Uterine insulin-like growth factor-1: Regulation of expression and its role in estrogen-induced uterine proliferation. Endocr. Rev., 11: 443-453, 1990.
40. Kleinman, D., Karas, M., Roberts-CT, J., Leroith, D., Phillip, M., Segev, Y., Levy, J., and Sharoni, Y. Modulation of insulin-like growth factor I (IGF-1) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol. Endocrinology, 136: 2531-2537, 1995.
41. Leone, M., Costantini, C., Gallo, G., Voci, A., Massajoli, M., Messeni, L. M., and de. C. L. Role of growth factors in the human endometrium during aging. Maturitas, 16: 31-38, 1993.
42. Murphy, L. J., Murphy, L. C., and Friesen, H. G. Estrogen induces insulinlike growth factor-1 expression in the rat uterus. Mol. Endocrinol., 1: 445-450. 1987.
43. Huynh, H. T., and Pollak, M. Insulin-like growth factor 1 gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res., 53: 5585-5588, 1993.
44. Zhou, J., Dsupin, B. A., Giudice, L. C., and Bondy, C. A. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J. Clin. Endocrinol. Metab., 79: 1723-1734, 1994.
45. Tang, X. M., Rossi, M. J., Masterson, B. J., and Chegini, N. Insulin-like growth factor 1 (IGF-1). IGF-1 receptors, and IGF binding proteins 1-4 in human uterine tissue: Tissue localization and IGF-1 action in endometrial stromal and myometrial smooth muscle cells in vitro. Biol. Reprod., 50: 1113-1125, 1994.
46. Clarke, C. L., Adams, J. B., and Wren, B. G. Induction of estrogen sulfotransferase in the human endometrium by progesterone in organ culture. J. Clin. Endocrinol. Metab., 55: 70-75, 1982.
47. Kitawaki, J., Yamamoto, T., and Okada, H. Induction of estradiol dehydrogenase activity in human uterine endometrium by synthetic steroids. J. Endocrinol. Investig., 11: 351-354, 1988.
48. Gao, J. G., Mazella, J., and Tseng, L. Activation of the human IGFBP-1 gene promoter by progestin and relaxin in primary culture of human endometrial stromal cells. Mol. Cell. Endocrinol., 104: 39-46, 1994.
49. Liu, H. C., He, Z. Y., Mele, C., Damario, M., Davis, O., and Rosenwaks, Z. Hormonal regulation of expression of messenger RNA encoding insulin-like growth factor binding proteins in human endometrial stromal cells cultured in vitro. Mol. Hum. Reprod., 3: 21-26, 1997.
50. Bell, S. C., Jackson, J. A., Ashmore, J., Zhu, H. H., and Tseng, L. Regulation of insulin-like growth factor-binding protein-1 synthesis and secretion by progestin and relaxin in long term cultures of human endometrial stromal cells. J. Clin. Endocrinol. Metab., 72: 1014-1024, 1991.
51. Suvanto-Luukkonen, E., Sundstrom, H., Penttinen, J., Kauppila, A., and Rutanen, E. M. Insulin-like growth factor-binding protein-1: A biochemical marker of endometrial response to progestin during hormone replacement therapy. Maturitas, 22: 255-262, 1995.
52. Rutanen, E. M., Nyman, T., Lehtovirta, P., Ammala, M., and Pekonen, F. Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: A molecular mechanism associating endometrial cancer with its risk factors. Int. J. Cancer, 59: 307-312, 1994.
53. Bell, S. C. The insulin-like growth factor binding proteins-the endometrium and decidua. Ann. N. Y. Acad. Sci., 622: 120-137, 1991.
54. Weiderpass, E., Adami, H. O., Baron, J. A., Magnusson, C., Lindgren, A., and Persson, I. Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control, 10: 277-284, 1999.
55. Grady, D., Gebretsadik, T., Kerlikowske, K., Emster, V., and Petitti, D. Hormone replacement therapy and endometrial cancer risk: A meta-analysis. Obstet. Gynecol., 85: 304-313, 1995.
56. Pike, M. C., and Ross, R. K. Progestins and menopause: Epidemiological studies of risks of endometrial and breast cancer. Steroids, 65: 659-664, 2000.
57. Weiderpass, E., Adami, H. O., Baron, J. A., Magnusson, C., Bergstrom, R., Lindgren, A., Correia, N., and Persson, I. Risk of endometrial cancer following estrogen replacement with and without progestins. J. Natl. Cancer Inst. (Bethesda), 91: 1131-1137, 1999.
58. Akhmedkhanov, A., Zeleniuch-Jacquotte, A., and Toniolo, P. Role of exogenous and endogenous hormones in endometrial cancer: Review of the evidence and research perspectives. Ann. N. Y. Acad. Sci., 943: 296-315, 2001.
59. Judd, H. L., Lucas, W. E., and Yen, S. S. Serum 17 β-estradiol and estrone levels in postmenopausal women with and without endometrial cancer. J. Clin. Endocrinol. Metab., 43: 272-278, 1976.
60. Judd, H. L., Davidson, B. J., Frumar, A. M., Shamonki, I. M., Lagasse, L. D., and Ballon, S. C. Serum androgens and estrogens in postmenopausal women with and without endometrial cancer. Am. J. Obstet. Gynecol., 136: 859-871, 1980.
61. Davidson, B. J., Gambone, J. C., Lagasse, L. D., Castaldo, T. W., Hammond, G. L., Siiteri, P. K., and Judd, H. L. Free estradiol in postmenopausal women with and without endometrial cancer. J. Clin. Endocrinol. Metab., 52: 404-408, 1981.
62. Falsetti, L., Omodei, U., Dordoni, D., Scagliola, P., Turla, R., Zotti, L., and Archetti, L. Profiles and endocrine correlations in endometrial carcinoma. Eur. J. Gynaecol. Oncol., 4: 30-34, 1983.
63. Jasonni, V. M., Bulletti, C., Franceschetti, F., Bonavia, M., Bolelli, G., Ciotti, P., and Flamigni, C. Estrone sulphate plasma levels in postmenopausal women with and without endometrial cancer. Cancer (Phila.), 53: 2698-700, 1984.
64. Bonney, R. C., Scanlon, M. J., Jones, D. L., Reed, M. J., Anderson, M. C., and James, V. H. The relationship between oestradiol metabolism and adrenal steroids in the endometrium of postmenopausal women with and without endometrial cancer. Eur. J. Cancer Clin. Oncol., 22: 953-961, 1986.
65. Schenker, J. G., Weinstein, D., and Okon, E. Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer. Cancer (Phila.), 44: 1809-1812, 1979.
66. Scirpa, P., Mango, D., Battaglia, F., Scirpa, S., and Montemurro, A. Plasma androstenedione and oestrone levels before and after the menopause. 1. Glandular hyperplasia and adenocarcinoma of the endometrium. Maturitas, 4: 33-42, 1982.
67. Bremond, A. G., Claustrat, B., Rudigoz, R. C., Seffert, P., and Comiau, J. Estradiol, androstenedione, testosterone, and dehydroepiandrosterone sulfate in the ovarian and peripheral blood of postmenopausal patients with and without endometrial cancer. Gynecol. Oncol., 14: 119-124, 1982.
68. Benjamin, F., and Deutsch, S. Plasma levels of fractionated estrogens and pituitary hormones in endometrial carcinoma. Am. J. Obstet. Gynecol., 126: 638-647, 1976.
69. Aleem, F. A., Moukhtar, M. A., Hung, H. C., and Romney, S. L. Plasma estrogen in patients with endometrial hyperplasia and carcinoma. Cancer (Phila.), 38: 2101-2104, 1976.
70. Oettinger, M., Samberg, I., Levitan, Z., Eibschitz, I., and Sharf, M. Hormonal profile of endometrial cancer. Gynecol. Obstet. Investig., 17: 225-235, 1984.
71. Pettersson, B., Bergstrom, R., and Johansson, E. D. Serum estrogens and androgens in women with endometrial carcinoma. Gynecol. Oncol., 25: 223-233, 1986.
72. Gimes, G., Szarvas, Z., and Siklosi, G. Endocrine factors in the etiology of endometrial carcinoma. Neoplasma, 33: 393-397, 1986.
73. Nyholm, H. C., Nielsen, A. L., Lyndrup, J., Dreisler, A., Hagen, C., and Haug, E. Plasma oestrogens in postmenopausal women with endometrial cancer. Br. J. Obstet. Gynaecol., 100: 1115-1119, 1993.
74. Carlstrom, K., Damber, M. G., Furuhjelm, M., Joelsson, I., Lunell, N. O., and von Schoultz, B. Serum levels of total dehydroepiandrosterone and total estrone in postmenopausal women with special regard to carcinoma of the uterine corpus. Acta Obstet. Gynecol. Scand., 58: 179-181, 1979.
75. Nisker, J. A., Hammond, G. L., Davidson, B. J., Frumar, A. M., Takaki, N. K., Judd, H. L., and Siiteri, P. K. Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma. Am. J. Obstet. Gynecol., 138: 637-642, 1980.
76. von Holst, T., Klinga, K., and Runnebaum, B. Hormone levels in healthy post-menopausal women and in women with post-menopausal bleeding with or without endometrial carcinoma. Maturitas, 3: 315-320, 1981.
77. Zeleniuch-Jacquotte, A., Akhmedkhanov, A., Kato, I., Koenig, K. L., Shore, R. E., Kim, M. Y., Levitz, M., Mittal, K. R., Raju, U., Banerjee, S., and Toniolo, P. Postmenopausal endogenous oestrogens and risk of endometrial cancer: Results of a prospective study. Br. J. Cancer, 84: 975-981, 2001.
78. Nagamani, M., Hannigan, E. V., Dillard, E. A., Jr., and Van Dinh, T. Ovarian steroid secretion in postmenopausal women with and without endometrial cancer. J. Clin. Endocrinol. Metab., 62: 508-512, 1986.
79. Stanczyk, F. Z. Steroid hormones. In: R. A. Lobo, D. R. Mishell Jr., R. J. Paulson, and D. Shoupe (eds.), Infertility, contraception, and reproductive endocrinology, pp. 46-66. Massachusetts: Blackwell Science, 1997.
80. Vitoratos, N., Gregoriou, O., Hassiakos, D., and Zourlas, P. A. The role of androgens in the late-premenopausal woman with adenomatous hyperplasia of the endometrium. Int. J. Gynaecol. Obstet., 34: 157-161, 1991.
81. Terada, S., Suzuki, N., Uchide, K., Akasofu, K., and Nishida, E. Effects of testosterone on the development of endometrial tumors in female rats. Gynecol. Obstet. Investig., 36: 29-33, 1993.
82. Anovulation and the polycystic ovary. In: L. Speroff, R. H. Glass, and N. G. Kase (eds.), Clinical Gynecologic Endocrinology and Infertility, pp. 457-482. Philadelphia: Lippincott, Williams & Wilkins, 1994.
83. Adams, J., Polson, D. W., and Franks, S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. Clin. Res. Ed., 293: 355-359, 1986.
84. Polson, D. W., Adams, J., Wadsworth, J., and Franks, S. Polycystic ovaries - A common finding in normal women. Lancet, 1: 870-872, 1988.
85. Franks, S. Polycystic ovary syndrome: A changing perspective. Clin. Endocrinol. (Oxf.), 31: 87-120, 1989.
86. Asuncion, M., Calvo, R. M., San Millan, J. L., Sancho, J., Avila, S., and Escobar-Morreale, H. F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab., 85: 2434-2438, 2000.
87. Sommers, S. C., Hertig, A. T., and Bengloff, H. Genesis of endometrial carcinoma, II. Cases 19 to 35 years old. Cancer (Phila.), 2: 957-963, 1949.
88. Shu, X. O., Brinton, L. A., Zheng, W., Gao, Y. T., Fan, J., and Fraumeni-JF, Jr. A population-based case-control study of endometrial cancer in Shanghai, China. Int. J. Cancer. 49: 38-43, 1991.
89. Escobedo, L. G., Lee, N. C., Peterson, H. B., and Wingo, P. A. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet. Gynecol., 77: 124-128, 1991.
90. Niwa, K., Imai, A., Hashimoto, M., Yokoyama, Y., Mori, H., Matsuda, Y., and Tamaya, T. A case-control study of uterine endometrial cancer of pre- and post-menopausal women. Oncol. Rep., 7: 89-93, 2000.
91. Modan, B., Ron, E., Lerner, G. L., Blumstein, T., Menczer, J., Rabinovici, J., Oelsner, G., Freedman, L., Mashiach, S., and Lunenfeld, B. Cancer incidence in a cohort of infertile women. Am. J. Epidemiol., 147: 1038-1042, 1998.
92. Wild, S., Pierpoint, T., Jacobs, H., and McKeigue, P. Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study. Hum. Fertil. (Camb.)., 3: 101-105, 2000.
93. Coulam, C. B., Annegers, J. F., and Kranz, J. S. Chronic anovulation syndrome and associated neoplasia. Obstet. Gynecol., 61: 403-407, 1983.
94. Nagamani, M., Stuart, C. A., and Doherty, M. G. Increased steroid production by the ovarian stromal tissue of postmenopausal women with endometrial cancer. J. Clin. Endocrinol. Metab., 74: 172-176, 1992.
95. Barbieri, R. L., Makris, A., Randall, R. W., Daniels, G., Kistner, R. W., and Ryan, K. J. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab., 62: 904-910, 1986.
96. Nestler, J. E., Jakubowicz, D. J., de Vargas, A. F., Brik, C., Quintero, N., and Medina, F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J. Clin. Endocrinol. Metab., 83: 2001-2005, 1998.
97. Botella-Llusia, J., Oriol-Bosch, A., Sanchez-Garrido, F., and Tresguerres, J. A. Testosterone and 17 β-oestradiol secretion of the human ovary. II. Normal postmenopausal women, postmenopausal women with endometrial hyperplasia and postmenopausal women with adenocarcinoma of the endometrium. Maturitas, 2: 7-12, 1980.
98. Nagamani, M., Doherty, M. G., Smith, E. R., and Chandrasekhar, Y. Increased bioactive luteinizing hormone levels in postmenopausal women with endometrial cancer. Am. J. Obstet. Gynecol., 167: 1825-1830, 1992.
99. Henderson, B. E., Casagrande, J. T., Pike, M. C., Mack, T., Rosario, I., and Duke, A. The epidemiology of endometrial cancer in young women. Br. J. Cancer, 47: 749-756, 1983.
100. Parazzini, F., La Vecchia, C., Bocciolone, L., and Franceschi, S. The epidemiology of endometrial cancer. Gynecol. Oncol., 41: 1-16, 1991.
101. Mertens, H. J., Heineman, M. J., Koudstaal, J., Theunissen, P., and Evers, J. L. Androgen receptor content in human endometrium. Eur. J. Obstet. Gynecol. Reprod. Biol., 70: 11-13, 1996.
102. Horie, K., Takakura, K., Imai, K., Liao, S., and Mori, T. Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium. Hum. Reprod., 7: 1461-1466, 1992.
103. Hackenberg, R., Beck, S., Filmer, A., Hushmand, N. A., Kunzmann, R., Koch, M., Slater, E. P., and Schulz, K. D. Androgen responsiveness of the new human endometrial cancer cell line MFE-296. Int. J. Cancer, 57: 117-122, 1994.
104. Legro, R. S., Kunselman, A. R., Miller, S. A., and Satyaswaroop, P. G. Role of androgens in the growth of endometrial carcinoma: An in vivo animal model. Am. J. Obstet. Gynecol., 184: 303-308, 2001.
105. Tuckerman, E. M., Okon, M. A., Li, T., and Laird, S. M. Do androgens have a direct effect on endometrial function? An in vitro study. Fertil. Steril., 74: 771-779, 2000.
106. Neulen, J., Wagner, B., Runge, M., and Breckwoldt, M. Effect of progestins, androgens, estrogens and antiestrogens on 3H-thymidine uptake by human endometrial and endosalpinx cells in vitro. Arch. Gynecol., 240: 225-232, 1987.
107. O'Mara, B. A., Byers, T., and Schoenfeld, E. Diabetes mellitus and cancerrisk: A multisite case-control study. J. Chronic. Dis., 38: 435-441, 1985.
108. Adami, H. O., McLaughlin, J., Ekbom, A., Berne, C., Silverman, D., Hacker, D., and Persson, I. Cancer risk in patients with diabetes mellitus. Cancer Causes Control, 2: 307-314, 1991.
109. Weiderpass, E., Gridley, G., Persson, I., Nyren, O., Ekbom, A., and Adami, H. O. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int. J. Cancer, 71: 360-363, 1997.
110. Shoff, S. M., and Newcomb, P. A. Diabetes, body size, and risk of endometrial cancer. Am. J. Epidemiol., 148: 234-240, 1998.
111. La, V. C., Negri, E., Franceschi, S., D'Avanzo, B., and Boyle, P. A case-control study of diabetes mellitus and cancer risk. Br. J. Cancer, 70: 950-953, 1994.
112. Rutanen, E. M., Stenman, S., Blum, W., Karkkainen, T., Lehtovirta, P., and Stenman, U. H. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: Comparison of endometrial cancer patients with healthy controls. J. Clin. Endocrinol. Metab., 77: 199-204, 1993.
113. Ayabe, T., Tsutsumi, O., Sakai, H., Yoshikawa, H., Yano, T., Kurimoto, F., and Taketani, Y. Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer. Endocr. J., 44: 419-424, 1997.
114. Talavera, F., Reynolds, R. K., Roberts, J. A., and Menon, K. M. Insulin-like growth factor I receptors in normal and neoplastic human endometrium. Cancer Res., 50: 3019-3024, 1990.
115. Roy, R. N., Gerulath, A. H., Cecutti, A., and Bhavnani, B. R. Discordant expression of insulin-like growth factors and their receptor messenger ribonucleic acids in endometrial carcinomas relative to normal endometrium. Mol. Cell. Endocrinol., 153: 19-27, 1999.
116. Werner, H., and Leroith, D. The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res., 68: 183-223, 1996.
117. Nagamani, M., and Stuart, C. A. Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. Am. J. Obstet. Gynecol., 179: 6-12, 1998.
118. Irwin, J. C., de las, F. L., Dsupin, B. A., and Giudice, L. C. Insulin-like growth factor regulation of human endometrial stromal cell function: Coordinate effects on insulin-like growth factor binding protein-1, cell proliferation and prolactin secretion. Regul. Pept., 48: 165-177, 1993.
119. Clemmons, D. R. Insulin-Like Growth Factor Binding Proteins. In: J. L. Kostyo and H. M. Goodman (eds.), Hormonal Control of Growth, pp. 573-632. New York: Oxford University Press, 1999.
120. Rechler, M. M. Insulin-like growth factor binding proteins. Vitam. Horm., 47: 1-114, 1993.
121. Lee, P. D., Giudice, L. C., Conover, C. A., and Powell, D. R. Insulin-like growth factor binding protein-1: Recent findings and new directions. Proc. Soc. Exp. Biol. Med., 216: 319-357, 1997.
122. Franks, S., Kiddy, D. S., Hamilton-Fairley, D., Bush, A., Sharp, P. S., and Reed, M. J. The role of nutrition and insulin in the regulation of sex hormone binding globulin. J. Steroid Biochem. Mol. Biol., 39: 835-838, 1991.
123. Plymate, S. R., Matej, L. A., Jones, R. E., and Friedl, K. E. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J. Clin. Endocrinol. Metab., 67: 460-464, 1988.
124. Pasquali, R., Vicennati, V., Bertazzo, D., Casimirri, F., Pascal, G., Tortelli, O., and Labate, A. M. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group. Metabolism, 46: 5-9, 1997.
125. Leenen, R., van der, K. K., Seidell, J. C., Deurenberg, P., and Koppeschaar, H. P. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J. Clin. Endocrinol. Metab., 78: 1515-1520, 1994.
126. Turcato, E., Zamboni, M., De Pergola, G., Armellini, F., Zivelonghi, A., Bergamo-Andreis, I. A., Giorgino, R., and Bosello, O. Interrelationships between weight loss, body fat distribution and sex hormones in pre- and postmenopausal obese women. J. Intern. Med., 241: 363-372, 1997.
127. Bernasconi, D., Del Monte, P., Meozzi, M., Randazzo, M., Marugo, A., Badaracco, B., and Marugo, M. The impact of obesity on hormonal parameters in hirsute and nonhirsute women. Metabolism, 45: 72-75, 1996.
128. Abate, N. Insulin resistance and obesity. The role of fat distribution pattern. Diabetes Care, 19: 292-294, 1996.
129. Bjorntorp, P. Metabolic abnormalities in visceral obesity. Ann. Med., 24: 3-5, 1992.
130. Unger, R., and Foster, DW. Diabetes mellitus. In: J. D. Wilson and D. W. Foster (eds.), Williams Textbook of Endocrinology, pp. 1255-1333. Philadelphia: W. B. Saunders Company, 1998.
131. Randle, P. J., Garland, P. B., Hales, C. N., and Newsholme, E. A. The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1: 785-789, 1963.
132. Randle, P. J. Metabolic fuel selection: General integration at the whole-body level. Proc. Nutr. Soc., 54: 317-327, 1995.
133. Bjorntorp, P. Fatty acids, hyperinsulinemia, and insulin resistance: Which comes first? Curr. Opin. Lipidol., 5: 166-174, 1994.
134. Flier, J. S. Insulin receptors and insulin resistance. Annu. Rev. Med., 34: 145-160, 1983.
135. Kahn, C. R. Role of insulin receptors in insulin-resistant states. Metabolism, 29: 455-466, 1980.
136. Moller, D. E., and Flier, J. S. Insulin resistance - Mechanisms, syndromes, and implications. N. Engl. J. Med., 325: 938-948, 1991.
137. Peiris, A. N., Sothmann, M. S., Hennes, M. I., Lee, M. B., Wilson, C. R., Gustafson, A. B., and Kissebah, A. H. Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: Predictive values of selected indices in premenopausal women. Am. J. Clin. Nutr., 49: 758-764, 1989.
138. Kissebah, A. H., Vydelingum, N., Murray, R., Evans, D. J., Hartz, A. J., Kalkhoff, R. K., and Adams, P. W. Relation of body fat distribution to metabolic complications of obesity. J. Clin. Endocrinol. Metab., 54: 254-260, 1982.
139. Evans, D. J., Hoffmann, R. G., Kalkhoff, R. K., and Kissebah, A. H. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism, 33: 68-75, 1984.
140. Krotkiewski, M., Seidell, J. C., and Bjorntorp, P. Glucose tolerance and hyperinsulinaemia in obese women: Role of adipose tissue distribution, muscle fibre characteristics and androgens. J. Intern. Med., 228: 385-392, 1990.
141. Reaven, G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37: 1595-1607, 1988.
142. DeFronzo, R. A. Lilly lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes, 37: 667-687, 1988.
143. Lonnqvist, F., Thome, A., Nilsell, K., Hoffstedt, J., and Amer, P. A pathogenic role of visceral fat β3-adrenoceptors in obesity. J. Clin. Investig., 95: 1109-1116, 1995.
144. Marin, P., Andersson, B., Ottosson, M., Olbe, L., Chowdhury, B., Kvist, H., Holm, G., Sjostrom, L., and Bjorntorp, P. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism, 41: 1242-1248, 1992.
145. Colman, E., Katzel, L. I., Rogus, E., Coon, P., Muller, D., and Goldberg, A. P. Weight loss reduces abdominal fat and improves insulin action in middleaged and older men with impaired glucose tolerance. Metabolism, 44: 1502-1508, 1995.
146. Rasmussen, M. H., Juul, A., Kjems, L. L., Skakkebaek, N. E., and Hilsted, J. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. J. Clin. Endocrinol. Metab., 80: 796-801, 1995.
147. Dengel, D. R., Pratley, R. E., Hagberg, J. M., Rogus, E. M., and Goldberg, A. P. Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J. Appl. Physiol., 81: 318-325, 1996.
148. Torjesen, P. A., Birkeland, K. I., Anderssen, S. A., Hjermann, I., Holme, I., and Urdal, P. Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: A randomized trial. Diabetes Care, 20: 26-31, 1997.
149. Casimirri, F., Pasquali, R., Cesari, M. P., Melchionda, N., and Barbara, L. Interrelationships between body weight, body fat distribution and insulin in obese women before and after hypocaloric feeding and weight loss. Ann. Nutr. Metab., 33: 79-87, 1989.
150. Feskens, E. J., Loeber, J. G., and Kromhout, D. Diet and physical activity as determinants of hyperinsulinemia: The Zutphen Elderly Study. Am. J. Epidemiol., 140: 350-360, 1994.
151. Regensteiner, J. G., Mayer, E. J., Shetterly, S. M., Eckel, R. H., Haskell, W. L., Marshall, J. A., Baxter, J., and Hamman, R. F. Relationship between habitual physical activity and insulin levels among nondiabetic men and women. San Luis Valley Diabetes Study. Diabetes Care, 14: 1066-1074, 1991.
152. Wang, J. T., Ho, L. T., Tang, K. T., Wang, L. M., Chen, Y. D., and Reaven, G. M. Effect of habitual physical activity on age-related glucose intolerance. J. Am. Geriatr. Soc., 37: 203-209, 1989.
153. Koivisto, V. A., Yki, J. H., and DeFronzo, R. A. Physical training and insulin sensitivity. Diabetes Metab. Rev., 1: 445-481, 1986.
154. Bonen, A. Benefits of exercise for type II diabetics: Convergence of epidemiologic, physiologic, and molecular evidence. Can. J. Appl. Physiol., 20: 261-279, 1995.
155. Ivy, J. L. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Med., 24: 321-336, 1997.
156. Kelley, D. E., and Goodpaster, B. H. Effects of physical activity on insulin action and glucose tolerance in obesity. Med. Sci. Sports Exerc., 31: S619-S623, 1999.
157. van Baak, M. A., and Borghouts, L. B. Relationships with physical activity. Nutr. Rev., 58: S16-S18, 2000.
158. Godsland, I. F., Leyva, F., Walton, C., Worthington, M., and Stevenson, J. C. Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the Heart Disease and Diabetes Risk Indicators in a Screened Cohort study (HDDRISC-1). J. Intern. Med., 244: 33-41, 1998.
159. Thune, I., Njolstad, I., Lochen, M. L., and Forde, O. H. Physical activity improves the metabolic risk profiles in men and women: The Tromso Study. Arch. Intern. Med., 158: 1633-1640, 1998.
160. Raastad, T., Bjoro, T., and Hallen, J. Hormonal responses to high- and moderate-intensity strength exercise. Eur. J. Appl. Physiol., 82: 121-128, 2000.
161. Grimm, J. J. Interaction of physical activity and diet: Implications for insulin-glucose dynamics. Public Health Nutr., 2: 363-368, 1999.
162. Borghouts, L. B., and Keizer, H. A. Exercise and insulin sensitivity: A review. Int. J. Sports Med., 21: 1-12, 2000.
163. Lindgarde, F., and Saltin, B. Daily physical activity, work capacity and glucose tolerance in lean and obese normoglycaemic middle-aged men. Diabetologia, 20: 134-138, 1981.
164. Underwood, L. E., Thissen, J. P., Lemozy, S., Ketelslegers, J. M., and Clemmons, D. R. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm. Res., 42: 145-151, 1994.
165. Thissen, J. P., Ketelslegers, J. M., and Underwood, L. E. Nutritional regulation of the insulin-like growth factors. Endocr. Rev., 15: 80-101, 1994.
166. Frystyk, J., Vestbo, E., Skjaerbaek, C., Mogensen, C. E., and Orskov, H. Free insulin-like growth factors in human obesity. Metabolism, 44: 37-44, 1995.
167. Jones, J. I., and Clemmons, D. R. Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev., 16: 3-34, 1995.
168. Ketelslegers, J. M., Maiter, D., Maes, M., Underwood, L. E., and Thissen, J. P. Nutritional regulation of insulin-like growth factor-I.
169. Pugeat, M., Crave, J. C., Elmidani, M., Nicolas, M. H., Garoscio, C. M., Lejeune, H., Dechaud, H., and Tourniaire, J. Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin. J. Steroid Biochem. Mol. Biol., 40: 841-849, 1991.
170. Nestler, J. E. Obesity, insulin, sex steroids and ovulation. Int. J. Obes. Relat. Metab. Disord., 24 (Suppl. 2): S71-S73, 2000.
171. Crave, J. C., Fimbel, S., Lejeune, H., Cugnardey, N., Dechaud, H., and Pugeat, M. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J. Clin. Endocrinol. Metab., 80: 2057-2062, 1995.
172. Evans, D. J., Hoffmann, R. G., Kalkhoff, R. K., and Kissebah, A. H. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J. Clin. Endocrinol. Metab., 57: 304-310, 1983.
173. Peiris, A. N., Sothmann, M. S., Aiman, E. J., and Kissebah, A. H. The relationship of insulin to sex hormone-binding globulin: Role of adiposity. Fertil. Steril., 52: 69-72, 1989.
174. Seidell, J. C., Cigolini, M., Charzewska, J., Ellsinger, B. M., Di Biase, G., Bjorntorp, P., Hautvast, J. G., Contaldo, F., Szostak, V., and Scuro, L. A. Androgenicity in relation to body fat distribution and metabolism in 38-year-old women - The European Fat Distribution Study. J. Clin Epidemiol., 43: 21-34, 1990.
175. Kirschner, M. A., Samojlik, E., Drejka, M., Szmal, E., Schneider, G., and Ertel, N. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J. Clin. Endocrinol. Metab., 70: 473-479, 1990.
176. Weaver, J. U., Holly, J. M., Kopelman, P. G., Noonan, K., Giadom, C. G., White, N., Virdee, S., and Wass, J. A. Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clin. Endocrinol. (Oxf.), 33: 415-422, 1990.
177. Sharp, P. S., Kiddy, D. S., Reed, M. J., Anyaoku, V., Johnston, D. G., and Franks, S. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 35: 253-257, 1991.
178. Kaye, S. A., Folsom, A. R., Soler, J. T., Prineas, R. J., and Potter, J. D. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int. J. Epidemiol., 20: 151-156, 1991.
179. Haffner, S., M., Dunn, J. F., and Katz, M. S. Relationship of sex hormonebinding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism, 41: 278-284, 1992.
180. Preziosi, P., Barrett, C. E., Papoz, L., Roger, M., Saint, P. M., Nahoul, K., and Simon, D. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: The telecom study. J. Clin. Endocrinol. Metab., 76: 283-287, 1993.
181. Poretsky, L., Cataldo, N. A., Rosenwaks, Z., and Giudice, L. C. The insulin-related ovarian regulatory system in health and disease. Endocr. Rev., 20: 535-582, 1999.
182. Cara, J. F. Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm. Res., 42: 49-54, 1994.
183. Kaaks, R. Nutrition, hormones, and breast cancer: Is insulin the missing link? Cancer Causes Control, 7: 605-625, 1996.
184. Siiteri, P. K. Adipose tissue as a source of hormones. Am. J. Clin. Nutr., 45: 277-282, 1987.
185. Longcope, C., Pratt, J. H., Schneider, S. H., and Fineberg, S. E. Aromatization of androgens by muscle and adipose tissue in vivo. J. Clin. Endocrinol. Metab., 46: 146-152, 1978.
186. Perel, E., and Killinger, D. W. The interconversion and aromatization of androgens by human adipose tissue. J. Steroid Biochem., 10: 623-627, 1979.
187. Azziz, R. Reproductive endocrinologic alterations in female asymptomatic obesity. Fertil. Steril., 52: 703-725, 1989.
188. Katsouyanni, K., Boyle, P., and Trichopoulos, D. Diet and urine estrogens among postmenopausal women. Oncology, 48: 490-494, 1991.
189. Vermeulen, A., and Verdonck, L. Sex hormone concentrations in postmenopausal women. Clin. Endocrinol. (Oxf)., 9: 59-66, 1978.
190. MacDonald, P. C., Edman, C. D., Hemsell, D. L., Porter, J. C., and Siiteri, P. K. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am. J. Obstet. Gynecol., 130: 448-455, 1978.
191. Vermeuten, A. Sex hormone status of the postmenopausal woman. Maturitas, 2: 81-89, 1980.
192. Kirschner, M. A., Schneider, G., Ertel, N. H., and Worton, E. Obesity, androgens, estrogens, and cancer risk. Cancer Res., 42: 3281s-3285s, 1982.
193. Klinga, K., von Holst, T., and Runnebaum, B. Influence of severe obesity on peripheral hormone concentrations in pre- and postmenopausal women. Eur. J. Obstet. Gynecol. Reprod. Biol., 15: 103-112, 1983.
194. Bruning, P. F., Bonfrer, J. M., and Hart, A. A. Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk. Br. J. Cancer, 51: 479-484, 1985.
195. Enriori, C. L., Orsini, W., del-Carmen, C. M., Etkin, A. E., Cardillo, L. R., and Reforzo, M. J. Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: Reversible effect of weight loss. Gynecol. Oncol., 23: 77-86, 1986.
196. Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., and Pasternack, B. S. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl. Cancer Inst. (Bethesda), 87: 190-197, 1995.
197. Cauley, J. A., Gutai, J. P., Kuller, L. H., LeDonne, D., and Powell, J. G. The epidemiology of serum sex hormones in postmenopausal women. Am. J. Epidemiol., 129: 1120-1131, 1989.
198. Newcomb, P. A., Klein, R., Klein, B. E., Haffner, S., Mares-Perlman, J., Cruickshanks, K. J., and Marcus, P. M. Association of dietary and life-style factors with sex hormones in postmenopausal women. Epidemiology, 6: 318-321, 1995.
199. Verkasalo, P. K., Thomas, H. V., Appleby, P. N., Davey, G. K., and Key, T. J. Circulating levels of sex hormones and their relation to risk factors for breast cancer: A cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control. 12: 47-59, 2001.
200. Dorgan, J. F., Reichman, M. E., Judd, J. T., Brown, C., Longcope, C., Schatzkin, A., Albanes, D., Campbell, W. S., Franz, C., Kahle, L. and. The relation of body size to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States). Cancer Causes Control, 6: 3-8, 1995.
201. Thomas, H. V., Key, T. J., Allen, D. S., Moore, J. W., Dowsett, M., Fentiman, I. S., and Wang, D. Y. Re: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J. Natl. Cancer Inst. (Bethesda), 89: 396-398, 1997.
202. Nagata, C., Kaneda, N., Kabuto, M., and Shimizu, H. Factors associated with serum levels of estradiol and sex hormone-binding globulin among premenopausal Japanese women. Environ. Health Perspect., 105: 994-997, 1997.
203. de Ridder, C. M., Bruning, P. F., Zonderland, M. L., Thijssen, J. H., Bonfrer, J. M., Blankenstein, M. A., Huisveld, I. A., and Erich, W. B. Body fat mass, body fat distribution, and plasma hormones in early puberty in females. J. Clin. Endocrinol. Metab., 70: 888-893, 1990.
204. Holte, J., Bergh, T., Gennarelli, G., and Wide, L. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin. Endocrinol. (Oxf.)., 41: 473-481, 1994.
205. Zumoff, B. Hormonal abnormalities in obesity. Acta Med. Scand. Suppl., 723: 153-160, 1988.
206. Penttila, T. L., Koskinen, P., Penttila, T. A., Anttila, L., and Irjala, K. Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome. Fertil. Steril., 71: 457-461, 1999.
207. Morales, A. J., Laughlin, G. A., Butzow, T., Maheshwari, H., Baumann, G., and Yen, S. S. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: Common and distinct features. J. Clin. Endocrinol. Metab., 81: 2854-2864, 1996.
208. Ivandic, A., Prpic-Krizevac, I., Sucic, M., and Juric, M. Hyperinsulinemia and sex hormones in healthy premenopausal women: Relative contribution of obesity, obesity type, and duration of obesity. Metabolism, 47: 13-19, 1998.
209. Wajchenberg, B. L., Marcondes, J. A., Mathor, M. B., Achando, S. S., Germak, O. A., and Kirschner, M. A. Free testosterone levels during the menstrual cycle in obese versus normal women. Fertil. Steril., 51: 535-537, 1989.
210. Dunaif, A. Adrenal disorders and polycystic ovary syndrome. Horm. Res., 37 (Suppl. 3): 39-44, 1992.
211. Ehrmann, D. A., Barnes, R. B., and Rosenfield, R. L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr. Rev., 16: 322-353, 1995.
212. Franks, S. Polycystic ovary syndrome. N. Engl. J. Med., 333: 853-861, 1995.
213. Gonzalez, F. Adrenal involvement in polycystic ovary syndrome. Semin. Reprod. Endocrinol., 15: 137-157, 1997.
214. Chang, R. J., Nakamura, R. M., Judd, H. L., and Kaplan, S. A. Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 57: 356-359, 1983.
215. Dunaif, A., Graf, M., Mandeli, J., Laumas, V., and Dobrjansky, A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J. Clin. Endocrinol. Metab., 65: 499-507, 1987.
216. Dunaif, A., Segal, K. R., Futterweit, W., and Dobrjansky, A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38: 1165-1174, 1989.
217. Rittmaster, R. S., Deshwal, N., and Lehman, L. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome. J. Clin. Endocrinol. Metab., 76: 1295-1300, 1993.
218. Grulet, H., Hecart, A. C., Delemer, B., Gross, A., Sulmont, V., Leutenegger, M., and Caron, J. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin. Endocrinol. Oxf., 38: 621-626, 1993.
219. Rajkhowa, M., Bicknell, J., Jones, M., and Clayton, R. N. Insulin sensitivity in women with polycystic ovary syndrome: Relationship to hyperandrogenemia. Fertil. Steril., 61: 605-612, 1994.
220. Burghen, G. A., Givens, J. R., and Kitabchi, A. E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab., 50: 113-116, 1980.
221. Shoupe, D., Kumar, D. D., and Lobo, R. A. Insulin resistance in polycystic ovary syndrome. Am. J. Obstet. Gynecol., 147: 588-592, 1983.
222. Pasquali, R., Casimirri, F., Venturoli, S., Paradisi, R., Mattioli, L., Capelli, M., Melchionda, N., and Labo, G. Insulin resistance in patients with polycystic ovaries; its relationship to body weight and androgen levels. Acta Endocrinol. (Copenh.), 104: 110-116, 1983.
223. Wajchenberg, B. L., Giannella, N. D., Lerario, A. C., Marcondes, J. A., and Ohnuma, L. Y. Role of obesity and hyperinsulinemia in the insulin resistance of obese subjects with the clinical triad of polycystic ovaries, hirsutism and acanthosis nigricans. Horm. Res., 29: 7-13, 1988.
224. Pasquali, R., Casimirri, F., Venturoli, S., Antonio, M., Morselli, L., Reho, S., Pezzoli, A., and Paradisi, R. Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome. Metabolism, 43: 706-713, 1994.
225. Kiddy, D. S., Sharp, P. S., White, D. M., Scanlon, M. F., Mason, H. D., Bray, C. S., Polson, D. W., Reed, M. J., and Franks, S. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases. Clin. Endocrinol. (Oxf.)., 32: 213-220, 1990.
226. Robinson, S., Kiddy, D., Gelding, S. V., Willis, D., Niththyananthan, R., Bush, A., Johnston, D. G., and Franks, S. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin. Endocrinol. (Oxf.), 39: 351-355, 1993.
227. Barbieri, R. L., Smith, S., and Ryan, K. J. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil. Steril., 50: 197-212, 1988.
228. Kiddy, D. S., Hamilton, F. D., Seppala, M., Koistinen, R., James, V. H., Reed, M. J., and Franks, S. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: Correlation with serum insulin and insulin-like growth factor-I. Clin. Endocrinol. (Oxf.), 31: 757-763, 1989.
229. Bates, G. W., and Whitworth, N. S. Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil. Steril., 38: 406-409, 1982.
230. Harlass, F. E., Plymate, S. R., Fariss, B. L., and Belts, R. P. Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female. Fertil. Steril., 42: 649-652, 1984.
231. Birdsall, M. A., and Farquhar, C. M. Polycystic ovaries in pre and postmenopausal women. Clin. Endocrinol. (Oxf)., 44: 269-276, 1996.
232. Winters, S. J., Talbott, E., Guzick, D. S., Zborowski, J., and McHugh, K. P. Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil. Steril., 73: 724-729, 2000.
233. Pache, T. D., de Jong, F. H., Hop, W. C., and Fauser, B. C. Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertil. Steril., 59: 544-549, 1993.
234. Dewailly, D., Duhamel, A., Robert, Y., Ardaens, Y., Beuscart, R., Lemaitre, L., and Fossati, P. Interrelationship between ultrasonography and biology in the diagnosis of polycystic ovarian syndrome. Ann. N. Y. Acad. Sci., 687: 206-216, 1993.
235. Fulghesu, A. M., Ciampelli, M., Belosi, C., Apa, R., Pavone, V., and Lanzone, A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: The ovarian stroma/total area ratio. Fertil. Steril., 76: 326-331, 2001.
236. Poretsky, L., and Piper, B. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet. Gynecol., 84: 613-621, 1994.
237. Dunaif, A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr. Rev., 18: 774-800, 1997.
238. Futterweit, W. Pathophysiology of polycystic ovarian syndrome. In: G. P. Redmond (ed.), Androgenic Disorders, pp. 77-166. New York: Raven Press Ltd, 1995.
239. Gharani, N., Waterworth, D. M., Batty, S., White, D., Gilling-Smith, C., Conway, G. S., McCarthy, M., Franks, S., and Williamson, R. Association of the steroid synthesis gene CYPIIa with polycystic ovary syndrome and hyperandrogenism. Hum. Mol. Genet., 6: 397-402, 1997.
240. Diamanti-Kandarakis, E., Bartzis. M. I., Bergiele, A. T., Tsianateli, T. C., and Kouli, C. R. Microsatellite polymorphism (utta)(n) at -528 base pairs of gene CYP11α influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertil. Steril., 73: 735-741, 2000.
241. Diamanti-Kandarakis, E., Bartzis, M. I., Zapanti, E. D., Spina, G. G., Filandra, F. A., Tsianateli, T. C., Bergiele, A. T., and Kouli, C. R. Polymorphism T→C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil. Steril., 71: 431-435, 1999.
242. Qin, K. N., and Rosenfield, R. L. Role of cytochrome P450c17 in polycystic ovary syndrome. Mol. Cell. Endocrinol., 145: 111-121, 1998.
243. Calvo, R. M., Villuendas, G., Sancho, J., San Millan, J. L., and EscobarMorreale, H. F. Role of the follistatin gene in women with polycystic ovary syndrome. Fertil. Steril., 75: 1020-1023, 2001.
244. Urbanek, M., Wu, X., Vickery, K. R., Kao, L. C., Christenson, L. K., Schneyer, A., Legro, R. S., Driscoll, D. A., Strauss, J. F., III, Dunaif, A., and Spielman, R. S. Allelic variants of the follistatin gene in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 85: 4455-4461, 2000.
245. McKeigue, P., and Wild, S. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome. Lancet, 349: 1771-1772, 1997.
246. Tong, Y., Liao, W. X., Roy, A. C., and Ng, S. C. Association of Accl polymorphism in the follicle-stimulating hormone β gene with polycystic ovary syndrome. Fertil. Steril., 74: 1233-1236, 2000.
247. Conway, G. S., Conway, E., Walker, C., Hoppner, W., Gromoll, J., and Simoni, M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 51: 97-99, 1999.